HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 10 of 79 for neuro
Dr. Cole is a pediatric neuro-oncologist who has dedicated her career to translational and clinical research, combining her expertise in molecular pathology, cancer genomics, and developmental therapeutics to identify novel treatments for children with cancer.
Dr. Belasco’s clinical and research work focuses on pediatric cancers, palliative care, neuro-oncology, neurofibromatosis, and lymphatic vascular malformations.
Dr. Avery is a principal investigator and an an attending physician in the Division of Ophthalmology at Children’s Hospital of Philadelphia.
Dr. Shah's clinical research interests are focused in the areas of neurofibromatosis type 1 and retinoblastoma. These studies range from translational studies to clinical trials of novel therapeutics to international consortiums studying long-term effects of therapy.
Published on Oct 17, 2016 in Press Releases
Collaboration with The Children's Brain Tumor Tissue Consortium, the Pacific Pediatric Neuro-Oncology Consortium, and Seven Bridges is Part of White House Precision Medicine Initiative
Dr. Baker develops point-of-care optical devices and neuro-diagnostics to guide the care of children at risk for brain injury. He also studies the interplay between the delivery of pediatric care and the patient's long-term brain health.
Dr. Van Batavia's long-term goal is to become a leader in neuro-urology and lower urinary tract dysfunction, with particular emphasis on deciphering the pathophysiology of lower urinary tract dysfunction and translating developments in the basic science arena into clinical improvements for patients.
Pioneering and advancing research methods for pediatric eye diseases, including retinal degeneration, retinopathy of prematurity, pediatric glaumcoma, and neuro-ophthalmology.
Published on Feb 11, 2016 in Cornerstone Blog
Daniel Smith, a research associate in the lab of Carol Armstrong, PhD, ABN, director of the Neuropsychology Lab in the Neuro-Oncology Program at CHOP, was announced the award winner at the PNS Monthly Meeting Jan. 27.
The Wilson Lab studies the inherited neuro- and cardio-degenerative mitochondrial disorder, Friedreich ataxia (FA). The lab also constructed the first random shRNA-expressing libraries and is using these libraries for drug discovery in a variety of disorders.